Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Walenga

Showing results (61-70 of 196) with videos related to

Pageof 20
Sort By:
Seminars in Thrombosis and Hemostasis|April 1, 1991
Comparative studies on various assays for the laboratory evaluation of r-hirudinJ M Walenga, D Hoppensteadt, M Koza, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1991
An objective perspective on recombinant hirudin: a new anticoagulant and antithrombotic agentJ Fareed, J M Walenga, L Iyer, et al.
Haemostasis|January 1, 1986
Laboratory studies on the intravenous and subcutaneous administration of PK 10169 in manJ Fareed, J M Walenga, D A Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1986
Coagulant versus amidolytic properties of human and bovine thrombins: implications in standardization and diagnostic usageJ Fareed, J M Walenga, L G Svendsen, et al.
Annals of the New York Academy of Sciences|January 1, 1989
Biochemical and pharmacologic inequivalence of low molecular weight heparinsJ Fareed, J M Walenga, D Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1989
Chemical and biological heterogeneity in low molecular weight heparins: implications for clinical use and standardizationJ Fareed, J M Walenga, D Hoppensteadt, et al.
Burns : Journal of the International Society for Burn Injuries|February 13, 2001
The impact of antithrombin (H) concentrate infusions on pulmonary function in the acute phase of thermal injuryA Kowal-Vern, J M Walenga, V McGill, et al.
The Annals of Thoracic Surgery|August 1, 1996
Efficacy of aprotinin with various anticoagulant agents in cardiopulmonary bypassM R Terrell, J M Walenga, M J Koza, et al.
Expert Opinion on Investigational Drugs|June 1, 1997
Low molecular weight heparins: a developmental perspectiveJ Fareed, D Hoppensteadt, W Jeske, et al.
Radiology|February 1, 1990
Thrombogenic potential of nonionic contrast media?J Fareed, J M Walenga, G E Saravia, et al.
Pageof 20

Showing results (61-70 of 196) with videos related to

Sort By:
Pageof 20
Seminars in Thrombosis and Hemostasis|April 1, 1991
Comparative studies on various assays for the laboratory evaluation of r-hirudinJ M Walenga, D Hoppensteadt, M Koza, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1991
An objective perspective on recombinant hirudin: a new anticoagulant and antithrombotic agentJ Fareed, J M Walenga, L Iyer, et al.
Haemostasis|January 1, 1986
Laboratory studies on the intravenous and subcutaneous administration of PK 10169 in manJ Fareed, J M Walenga, D A Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1986
Coagulant versus amidolytic properties of human and bovine thrombins: implications in standardization and diagnostic usageJ Fareed, J M Walenga, L G Svendsen, et al.
Annals of the New York Academy of Sciences|January 1, 1989
Biochemical and pharmacologic inequivalence of low molecular weight heparinsJ Fareed, J M Walenga, D Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1989
Chemical and biological heterogeneity in low molecular weight heparins: implications for clinical use and standardizationJ Fareed, J M Walenga, D Hoppensteadt, et al.
Burns : Journal of the International Society for Burn Injuries|February 13, 2001
The impact of antithrombin (H) concentrate infusions on pulmonary function in the acute phase of thermal injuryA Kowal-Vern, J M Walenga, V McGill, et al.
The Annals of Thoracic Surgery|August 1, 1996
Efficacy of aprotinin with various anticoagulant agents in cardiopulmonary bypassM R Terrell, J M Walenga, M J Koza, et al.
Expert Opinion on Investigational Drugs|June 1, 1997
Low molecular weight heparins: a developmental perspectiveJ Fareed, D Hoppensteadt, W Jeske, et al.
Radiology|February 1, 1990
Thrombogenic potential of nonionic contrast media?J Fareed, J M Walenga, G E Saravia, et al.
Pageof 20